Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone for aggression after traumatic brain injury
ISRCTN30191436Phase 4Completed
- Sponsor
- Central and North West London NHS Foundation Trust
- Start
- Jan 2017
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of risperidone in traumatic brain injury (TBI), sponsored by Central and North West London NHS Foundation Trust. Started Jan 2017; status: completed.
02
Drugs
risperidone
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ISRCTN30191436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN30191436.